| Literature DB >> 30859794 |
Yahaya A Aliyu1,2, Joel O Botai1,3.
Abstract
Zaria is the educational hub of northern Nigeria. It is a developing city with a pollution level high enough to be ranked amongst the World Health Organization's (WHO) most polluted cities. The study appraised the influence of outdoor air pollution on the respiratory well-being of a population in a limited resource environment. With the approved ethics, the techniques utilized were: portable pollutant monitors, respiratory health records, WHO AirQ+ software, and the American Thoracic Society (ATS) questionnaire. They were utilized to acquire day-time weighted outdoor pollution levels, health respiratory cases, assumed baseline incidence (BI), and exposure respiratory symptoms among selected study participants respectively. The study revealed an average respiratory illness incidence rate of 607 per 100,000 cases. Findings showed that an average of 2648 cases could have been avoided if the theoretical WHO threshold limit for the particulate matter with diameter of <2.5/10 micron (PM2.5/PM10) were adhered to. Using the questionnaire survey, phlegm was identified as the predominant respiratory symptom. A regression analysis showed that the criteria pollutant PM2.5, was the most predominant cause of respiratory symptoms among interviewed respondents. The study logistics revealed that outdoor pollution is significantly associated with respiratory well-being of the study population in Zaria, Nigeria. © Atlantis Press International B.V.Entities:
Keywords: Air pollution; Zaria; respiratory health
Mesh:
Substances:
Year: 2018 PMID: 30859794 PMCID: PMC7325812 DOI: 10.2991/j.jegh.2018.04.002
Source DB: PubMed Journal: J Epidemiol Glob Health ISSN: 2210-6006
Figure 1The study area showing the distribution of pollution sample sites and government health facilities from which respiratory health records were obtained
Figure 2Portable air pollutant detectors (MSA Altair 5×/Chinaway CW-HAT200)
Figure 3Histogram of seasonal day-time pollutant concentrations across the 19 sampling sites (A) CO; (B) SO2; (C) PM2.5; (D) PM10. (Sites 3, 6, and 18 are control sites). DJF, December–January–February; MAM, March–April–May; JJA, June–July–August; SON, September–October–November
Recorded respiratory cases and related deaths in Zaria metropolis, 2011–2016
| 2011 | 4992 | 635 | 2065 (41.4) | 1650 (33.0) | 784 (15.7) | 493 (9.9) | 2746 (55.0) | 2246 (45.0) | 78 | 1.6 |
| 2012 | 5996 | 741 | 1498 (25.0) | 2757 (46.0) | 1126 (18.8) | 615 (10.2) | 3525 (58.8) | 2471 (41.2) | 95 | 1.6 |
| 2013 | 3003 | 360 | 815 (27.1) | 1361 (45.3) | 482 (16.1) | 345 (11.5) | 1694 (56.4) | 1309 (43.6) | 45 | 1.5 |
| 2014 | 3297 | 383 | 1056 (32.0) | 1302 (39.5) | 554 (16.8) | 385 (11.7) | 1909 (57.9) | 1388 (42.1) | 112 | 3.4 |
| 2015 | 5428 | 614 | 1757 (32.4) | 2392 (44.1) | 826 (15.2) | 453 (8.3) | 3136 (57.8) | 2292 (42.2) | 66 | 1.2 |
| 2016 | 8326 | 914 | 2818 (33.8) | 3522 (42.3) | 1313 (15.8) | 673 (8.1) | 4993 (60.0) | 3333 (40.0) | 65 | 0.8 |
Derived from the yearly population estimates; CFR, case fatality rates.
Descriptive statistics of respiratory symptoms among interviewed respondents in the study area
| Study population, | 352 (88.9) | 44 (11.1) | 396 |
| Age (years) | |||
| 20–29 | 38 | 15 | 53 (13.4) |
| 30–39 | 133 | 10 | 143 (36.1) |
| 40–49 | 149 | 9 | 158 (39.9) |
| ≥ 50 | 32 | 10 | 42 (10.6) |
| Education | |||
| Primary | 33 | 2 | 35 (8.9) |
| Secondary | 169 | 16 | 185 (46.7) |
| Tertiary | 150 | 26 | 176 (44.4) |
| Respiratory conditions | |||
| Chest cough | 289 | 31 | 320 (80.8) |
| Phlegm | 344 | 41 | 385 (97.2) |
| Cough & phlegm | 200 | 17 | 217 (54.8) |
| Wheeze | 175 | 22 | 197 (49.8) |
| Breathlessness | 192 | 28 | 220 (55.6) |
| Past illnesses | |||
| Lung trouble before 16 y | 18 | 3 | 21 (8.3) |
| Bronchitis attack | 14 | 3 | 17 (4.3) |
| Pneumonia attack | 47 | 9 | 56 (14.1) |
| Asthma attack | 15 | 4 | 19 (4.8) |
| Emphysema | 31 | 1 | 32 (8.1) |
| Hay fever | 2 | – | 2 (0.5) |
| Chest illness | 5 | 1 | 6 (1.5) |
| Chest operation | 3 | – | 3 (0.8) |
| Chest injury | 12 | 2 | 14 (3.5) |
| Heart trouble | 5 | 3 | 8 (2.0) |
| High blood pressure | 23 | 5 | 28 (7.1) |
| Hereditary probability | |||
| Father | 36 | 3 | 39 (9.9) |
| Mother | 60 | 10 | 70 (17.7) |
Threshold of selected air pollutants, modified after (FEPA, 1999; [45])
| FEPA | 20 | – | 150 | 0.1 |
| WHO | 9 | 25 | 50 | 0.01 |
WHO, World Health Organization; FEPA, Federal Environmental Protection Agency.
WHO theoretical values of relative risks (RR) implemented in AirQ+ corresponding to hospital admission/access for respiratory diseases and estimated RR in percentage and excess of number cases in 2016 resulting from short-term exposure to PM2.5/PM10 above the 10/20 μg/m−3 limits, respectively
| PM2.5 | 10 | 1.019 (0.9982–1.0402) | 219.73 | 1.4840 (0.9629–2.2856) | 2798 | 298.10 |
| PM10 | 20 | 1.008 (1.0048–1.0112) | 451.89 | 1.4108 (1.235–1.6177) | 2498 | 271.27 |
The PM2.5 and PM10 threshold limit prescribed by the WHO for theoretical baseline incidence per 100,000 is 1260; CI, confidence interval; RR, relative risks; WHO, World Health Organization.
Relationship between individual respiratory symptoms from respondents and each observed pollutants level
| CO | 0.90 | 29.61 | 0.86 | 33.63 | 0.79 | 10.68 | 0.80 | 15.72 | 0.82 | 13.71 |
| SO2 | 0.91 | 28.44 | 0.87 | 33.07 | 0.81 | 10.17 | 0.80 | 15.61 | 0.78 | 14.86 |
| PM2.5 | 0.89 | 31.17 | 0.87 | 32.95 | 0.90 | 7.60 | 0.80 | 15.71 | 0.76 | 15.36 |
| PM10 | 0.88 | 32.88 | 0.83 | 37.04 | 0.79 | 10.45 | 0.71 | 18.63 | 0.72 | 16.54 |
Shaded cell highlights the possible association of pollution exposure and respiratory condition; R, correlation coefficient; RMSE, root mean square error.
Figure 4Scatter plot showing strong positive relationship between criteria pollutants (A) CO; (B) SO2; (C) PM2.5; and (D) PM10 respectively) against at-risk population respondents from the sample sites